Your browser doesn't support javascript.
loading
Omics and drug response.
Meyer, Urs A; Zanger, Ulrich M; Schwab, Matthias.
Affiliation
  • Meyer UA; Division of Pharmacology and Neurobiology, Biozentrum of the University of Basel, CH-4056 Basel, Switzerland. urs-a.meyer@unibas.ch
Annu Rev Pharmacol Toxicol ; 53: 475-502, 2013.
Article in En | MEDLINE | ID: mdl-23140244
A new generation of technologies commonly named omics permits assessment of the entirety of the components of biological systems and produces an explosion of data and a major shift in our concepts of disease. These technologies will likely shape the future of health care. One aspect of these advances is that the data generated document the uniqueness of each human being in regard to disease risk and treatment response. These developments have reemphasized the concept of personalized medicine. Here we review the impact of omics technologies on one key aspect of personalized medicine: the individual drug response. We describe how knowledge of different omics may affect treatment decisions, namely drug choice and drug dose, and how it can be used to improve clinical outcomes.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Genomics Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Annu Rev Pharmacol Toxicol Year: 2013 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Genomics Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Annu Rev Pharmacol Toxicol Year: 2013 Type: Article Affiliation country: Switzerland